Luke Gammon
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
- Oncology 14
- Cancer Cells and Metastasis 11
- Cancer-related Molecular Pathways 3
- Cancer Immunotherapy and Biomarkers 2
-
- Wnt/β-catenin signaling in development and cancer 3
- Co-authors
- Ian C. Mackenzie (15 shared papers)Adrian Biddle (12 shared papers)Daniela Elena Costea (4 shared papers)Bilal Fazil (5 shared papers)Kristina Xiao Liang (2 shared papers)Lisa J. Harper (4 shared papers)Helena Emich (3 shared papers)Harshad Navsaria (2 shared papers)
- Journals
- Journal of Oral Pathology and Medicine (3 papers)PLoS ONE (2 papers)Journal of Investigative Dermatology (2 papers)Cancer Research (2 papers)Oncotarget (2 papers)
- Partner nations
- United KingdomNorwayJapan
In The Last Decade
Luke Gammon
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Cancer Research 308
- Oncology 525
- Cell Biology 310
- Molecular Biology 557
- Biotechnology 60
Countries citing papers authored by Luke Gammon
This map shows the geographic impact of Luke Gammon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Gammon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Gammon more than expected).
Fields of papers citing papers by Luke Gammon
This network shows the impact of papers produced by Luke Gammon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Gammon. The network helps show where Luke Gammon may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Gammon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 291 | |
| 2 | 2008 | 173 | |
| 3 | 2016 | 117 | |
| 4 | 2010 | 86 | |
| 5 | 2013 | 69 | |
| 6 | 2013 | 65 | |
| 7 | 2013 | 59 | |
| 8 | 2017 | 50 | |
| 9 | 2012 | 36 | |
| 10 | 2015 | 33 | |
| 11 | 2015 | 32 | |
| 12 | 2009 | 31 | |
| 13 | 2018 | 25 | |
| 14 | 2021 | 21 | |
| 15 | 2021 | 19 | |
| 16 | 2020 | 18 | |
| 17 | 2014 | 18 | |
| 18 | 2010 | 8 | |
| 19 | 2023 | 7 | |
| 20 | 2008 | 5 |
About Luke Gammon
Luke Gammon is a scholar working on Oncology, Molecular Biology, Cell Biology, Cancer Research and Genetics, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (11 papers), Skin and Cellular Biology Research (4 papers), Cancer-related Molecular Pathways (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Cellular Mechanics and Interactions (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Cancer Research (308 citations), Oncology (525 citations), Cell Biology (310 citations), Molecular Biology (557 citations) and Biotechnology (60 citations). Luke Gammon has collaborated with scholars based in United Kingdom, Norway and Japan. Frequent co-authors include Ian C. Mackenzie, Adrian Biddle, Daniela Elena Costea, Bilal Fazil, Kristina Xiao Liang, Lisa J. Harper, Helena Emich, Harshad Navsaria, Rosemary Jeffery and John A. McGrath. Their work appears in journals such as Journal of Oral Pathology and Medicine, PLoS ONE, Journal of Investigative Dermatology, Cancer Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.